Abstract
Sjogren's syndrome (SS) is a systemic autoimmune disease characterized by xerophthalmia, xerostomia and extraglandular manifestations. Anemia, leukopenia, thrombocytopenia and lymphoproliferative disorders, including lymphoma are well-known extraglandular, hematological complications of SS. We report here a rare case of patient with primary SS who developed pancytopenia with severe thrombocytopenia as an initial manifestation and successfully treated with IV immunoglobulin (IVIG). The present case suggests that pancytopenia with severe thrombocytopenia can be a difficult-to-treat abnormality, and initial manifestation of primary SS and IVIG might be an effective treatment for severe thrombocytopenia refractory to high-dose steroid in primary SS.
| Original language | English |
|---|---|
| Pages (from-to) | 1353-1355 |
| Number of pages | 3 |
| Journal | Rheumatology International |
| Volume | 32 |
| Issue number | 5 |
| DOIs | |
| State | Published - 2012.05 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- IV immunoglobulin
- Pancytopenia
- Primary Sjögren's syndrome
- Thrombocytopenia
Quacquarelli Symonds(QS) Subject Topics
- Medicine
- Biological Sciences
Fingerprint
Dive into the research topics of 'Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver